Venetoclax Latest Price and Buying Guide in 2024

Venetoclax, an oral drug hailed as a new hope in the treatment of blood cancers, has attracted widespread attention in the medical community due to its unique inhibitory mechanism targeting the B cell lymphoma-2 (BCL-2) protein. BCL-2The high expression of BCL-2 protein in cancer cells allows these cells to escape the natural apoptosis process, and venetoclax can effectively break this "protective umbrella", prompting cancer cells to enter an apoptotic state, thereby reducing the number of malignant cells.

Today, venetoclax has been successfully launched in China and has been successfully included in the medical insurance system, providing patients with more convenient drug purchase channels. In China, 100mg*28 capsules of venetoclax are sold for about 2,000 yuan. For specific prices and medical insurance reimbursement details, patients are advised to consult the local hospital pharmacy to obtain the most accurate information.

For patients looking for a more affordable option, foreign generic drugs may be a good consideration. Especially for generic drugs from Laos and Bangladesh, the price of 100mg*120 tablets is only about more than 2,000 yuan. There are even small-sized drugs that are more affordable, only a few hundred yuan. Compared with domestic imported original drugs, the price advantage is significant, and the ingredients of the drugs are basically the same.

Venetoclax has shown remarkable efficacy in the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML), especially for patients who have failed other treatments or whose disease has relapsed. However, the dose needs to be gradually increased during use to reduce the potential risk of tumor lysis syndrome, and relevant indicators must be strictly monitored under the guidance of a doctor to ensure that the treatment is safe and effective.